Patents by Inventor Larry Mimms

Larry Mimms has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240012007
    Abstract: An assay method for detecting the presence or amounts of VCAM-1 and A2M in a sample using fluorescence resonance energy transfer (FRET).
    Type: Application
    Filed: October 22, 2021
    Publication date: January 11, 2024
    Applicant: PROCISEDX INC.
    Inventors: Hongyu CHEN, Limin LIU, Stefan WESTIN, Michael HALE, Larry MIMMS
  • Patent number: 11860170
    Abstract: An assay method for detecting the presence or amounts of VCAM-1 and A2M in a sample using fluorescence resonance energy transfer (FRET).
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: January 2, 2024
    Assignee: ProciseDX Inc.
    Inventors: Hongyu Chen, Limin Liu, Stefan Westin, Michael Hale, Larry Mimms
  • Publication number: 20230160906
    Abstract: The disclosure provides fluorescence resonance energy transfer (FRET) assays to detect the presence of anti-TNF? biologics and/or their autoantibodies in a patient sample to monitor TNF? inhibitor therapy and to guide treatment decisions.
    Type: Application
    Filed: November 19, 2021
    Publication date: May 25, 2023
    Applicant: PROCISEDX INC.
    Inventors: JARED SALBATO, MARK RENSHAW, LARRY MIMMS
  • Publication number: 20230139053
    Abstract: An assay method for detecting the presence or amounts of VCAM-1 and A2M in a sample using fluorescence resonance energy transfer (FRET).
    Type: Application
    Filed: October 22, 2021
    Publication date: May 4, 2023
    Applicant: PROCISEDX INC.
    Inventors: Hongyu CHEN, Limin LIU, Stefan WESTIN, Michael HALE, Larry MIMMS
  • Publication number: 20230131780
    Abstract: The present disclosure provides solution based assays for detecting antibodies induced by SARS-CoV-2 (anti-SARS-CoV-2) in a biological sample.
    Type: Application
    Filed: October 21, 2022
    Publication date: April 27, 2023
    Applicant: PROCISEDX INC.
    Inventors: LARRY MIMMS, Michael Hale, Stefan Westin
  • Publication number: 20220283173
    Abstract: The present disclosure provides assay methods to detect and measure proteins in order to distinguish between a bacterial infection and a viral infection.
    Type: Application
    Filed: May 18, 2022
    Publication date: September 8, 2022
    Applicant: ProciseDx Inc.
    Inventors: Larry Mimms, Michael Hale
  • Publication number: 20220146501
    Abstract: An assay method for detecting the presence or amount of human serum albumin vitamin D, C-reactive protein, or anti-transglutaminase autoantibody (ATA) immunoglobulin A (IgA) and/or ATA IgG in a sample using fluorescence resonance energy transfer (FRET).
    Type: Application
    Filed: October 18, 2021
    Publication date: May 12, 2022
    Applicant: PROCISEDX INC.
    Inventors: JINYAO ZHOU, RAJ SRIKRISHNAN, SR., MICHAEL HALE, STEFAN WESTIN, MARK RENSHAW, LARRY MIMMS, RUKMINI REDDY
  • Publication number: 20220137035
    Abstract: An assay method for detecting and measuring the presence or amount of glycated hemoglobin in a sample using fluorescence resonance energy transfer (FRET).
    Type: Application
    Filed: November 8, 2021
    Publication date: May 5, 2022
    Applicant: Procisedx Inc.
    Inventors: Larry Mimms, Mark Renshaw, Kevin Chon, Michael Hale
  • Publication number: 20210405063
    Abstract: Assay methods for detecting the presence or amount of VCAM-1 or calprotectin in a sample using fluorescence resonance energy transfer (FRET).
    Type: Application
    Filed: September 3, 2021
    Publication date: December 30, 2021
    Applicant: PROCISEDX INC.
    Inventors: LIMIN LIU, HONGYU CHEN, STEFAN WESTIN, JINYAO ZHOU, MICHAEL HALE, LARRY MIMMS
  • Publication number: 20100151591
    Abstract: The present invention provides compositions and methods for detecting the presence of an analyte in a sample. Exemplary compositions comprise macrocyclic lanthanide complexes that are useful for transferring energy to an energy transfer acceptor to indicate the presence of the analyte. The compositions and methods are particularly suited for detecting antibodies in a sample.
    Type: Application
    Filed: November 2, 2009
    Publication date: June 17, 2010
    Inventors: Nathaniel G. Butlin, Larry Mimms